Plasma malondialdehyde in type 1 and type 2 diabetic patients
- 28 February 1993
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 214 (2) , 227-234
- https://doi.org/10.1016/0009-8981(93)90114-j
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Oxidized Low Density Lipoproteins: a Role in the Pathogenesis of Atherosclerosis in Diabetes?Diabetic Medicine, 1991
- Role of oxidatively modified LDL in atherosclerosisFree Radical Biology & Medicine, 1990
- Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.Journal of Clinical Investigation, 1989
- Does oxygen free radical increased formation explain long term complications of diabetes mellitus?Medical Hypotheses, 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- Malondialdehyde-Altered Protein Occurs in Atheroma of Watanabe Heritable Hyperlipidemic RabbitsScience, 1988
- Modification of human serum low density lipoprotein by oxidation — Characterization and pathophysiological implicationsChemistry and Physics of Lipids, 1987
- Increased Diene Conjugates in Diabetic Subjects with MicroangiopathyDiabetic Medicine, 1987
- Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitusDiabetologia, 1987
- Metabolism of malonaldehyde in vivo and in vitroLipids, 1982